Nuclear Medicine & Clinical Molecular Imaging

Positron emission tomography (PET) is an essential component of service in Nuclear Medicine and the trend is expected to continue as PET-CT becomes a routine service in the laboratory.

In addition to efforts to expand the reach of nuclear medicine technology, Nuclear Medicine has expanded its services to include therapeutic procedures that utilize radionuclides. Penn is a major source of referral for radioimmunotherapy for non-Hodgkin’s lymphoma and thyroid cancer in the Greater Philadelphia region.

Penn’s Nuclear Medicine Division has one of the strongest training programs in the country; the majority of graduates are recruited by prestigious academic institutions in the U.S. and around the world. PET, radioimmunotherapy and structural imaging are all a part of the curriculum and Abass Alavi,MD, has been able to secure funding for a T32 training program from the NIH for educating highly qualified individuals in novel imaging techniques. At a recent meeting of the Society of Nuclear Medicine, Penn Nuclear Medicine trainees presented more papers than those from any other center around the world.

Nuclear Medicine & Clinical Molecular Imaging Faculty List